{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T17:51:14Z","timestamp":1791568274405,"version":"4.3.4"},"reference-count":20,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,8,28]],"date-time":"2026-08-28T00:00:00Z","timestamp":1787875200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["elsevier.es","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Nefrolog\u00eda (English Edition)"],"published-print":{"date-parts":[[2026,10]]},"DOI":"10.1016\/j.nefroe.2026.501554","type":"journal-article","created":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T16:55:46Z","timestamp":1791564946000},"page":"501554","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Meningococcal meningitis in patients under prolonged eculizumab therapy: Clinical and immunological observations from a case series"],"prefix":"10.1016","volume":"46","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1241-9936","authenticated-orcid":false,"given":"Rub\u00e9n","family":"Varela-Fern\u00e1ndez","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luis","family":"Ortega-Val\u00edn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M\u00f3nica","family":"S\u00e1ez-Villafa\u00f1e","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cristina","family":"Lucas-\u00c1lvarez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juan Jos\u00e9","family":"Ortiz-de-Urbina-Gonz\u00e1lez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.nefroe.2026.501554_bib0105","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1182\/hematology.2024000543","article-title":"Atypical hemolytic uremic syndrome: diagnosis, management, and discontinuation of therapy","volume":"2024","author":"Java","year":"2024","journal-title":"Hematol Am Soc Hematol Educ Prog"},{"key":"10.1016\/j.nefroe.2026.501554_bib0110","doi-asserted-by":"crossref","first-page":"39","DOI":"10.3390\/biom14010039","article-title":"The role of the complement system in the pathogenesis of infectious forms of hemolytic uremic syndrome","volume":"14","author":"Avdonin","year":"2023","journal-title":"Biomolecules"},{"key":"10.1016\/j.nefroe.2026.501554_bib0115","doi-asserted-by":"crossref","first-page":"2233","DOI":"10.2147\/JMDH.S245620","article-title":"Atypical hemolytic\u2013uremic syndrome: genetic basis, clinical manifestations, and a multidisciplinary approach to management","volume":"16","author":"Yerigeri","year":"2023","journal-title":"J Multidiscip Healthc"},{"key":"10.1016\/j.nefroe.2026.501554_bib0120","doi-asserted-by":"crossref","DOI":"10.1177\/20406207241307500","article-title":"Current landscape of paroxysmal nocturnal hemoglobinuria in the era of complement inhibitors and regulators","volume":"15","author":"Shi","year":"2024","journal-title":"Ther Adv Hematol"},{"key":"10.1016\/j.nefroe.2026.501554_bib0125","doi-asserted-by":"crossref","first-page":"12104","DOI":"10.3390\/ijms252212104","article-title":"Thrombosis in paroxysmal nocturnal hemoglobinuria (PNH): from pathogenesis to treatment","volume":"25","author":"Kokoris","year":"2024","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.nefroe.2026.501554_bib0130","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1007\/s40259-025-00707-3","article-title":"The path to accessible care: development and impact of eculizumab biosimilars for paroxysmal nocturnal hemoglobinuria and atypical hemolytic uremic syndrome","volume":"39","author":"Jang","year":"2025","journal-title":"BioDrugs"},{"key":"10.1016\/j.nefroe.2026.501554_bib0135","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1182\/hematology.2020000171","article-title":"Rituximab and eculizumab when treating nonmalignant hematologic disorders: infection risk, immunization recommendations, and antimicrobial prophylaxis needs","volume":"2020","author":"Engel","year":"2020","journal-title":"Hematol Am Soc Hematol Educ Prog"},{"key":"10.1016\/j.nefroe.2026.501554_bib0140","doi-asserted-by":"crossref","first-page":"734","DOI":"10.15585\/mmwr.mm6627e1","article-title":"High risk for invasive meningococcal disease among patients receiving eculizumab (soliris) despite receipt of meningococcal vaccine","volume":"66","author":"McNamara","year":"2017","journal-title":"Morb Mortal Wkly Rep"},{"key":"10.1016\/j.nefroe.2026.501554_bib0145","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1007\/s00277-017-2924-y","article-title":"Serologic response to meningococcal vaccination in patients with paroxysmal nocturnal hemoglobinuria (PNH) chronically treated with the terminal complement inhibitor eculizumab","volume":"96","author":"Alashkar","year":"2017","journal-title":"Ann Hematol"},{"key":"10.1016\/j.nefroe.2026.501554_bib0150","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1093\/ndt\/gfy225","article-title":"Failure of first meningococcal vaccination in patients with atypical haemolytic uraemic syndrome treated with eculizumab","volume":"35","author":"G\u00e4ckler","year":"2020","journal-title":"Nephrol Dial Transplant"},{"issue":"Suppl. 2","key":"10.1016\/j.nefroe.2026.501554_bib0155","doi-asserted-by":"crossref","first-page":"S21","DOI":"10.1016\/j.cmi.2018.02.002","volume":"24","author":"Winthrop","year":"2018","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.nefroe.2026.501554_bib0160","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1080\/14760584.2019.1557520","article-title":"The Global Meningococcal Initiative meeting on prevention of meningococcal disease worldwide: Epidemiology, surveillance, hypervirulent strains, antibiotic resistance and high-risk populations","volume":"18","author":"Acevedo","year":"2019","journal-title":"Expert Rev Vac"},{"key":"10.1016\/j.nefroe.2026.501554_bib0165","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1182\/blood-2017-05-781450","article-title":"Eculizumab treatment and impaired opsonophagocytic killing of meningococci by whole blood from immunized adults","volume":"130","author":"Konar","year":"2017","journal-title":"Blood"},{"key":"10.1016\/j.nefroe.2026.501554_bib0170","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1016\/j.jinf.2019.11.015","article-title":"Antibiotic prophylaxis in vaccinated eculizumab recipients who developed meningococcal disease","volume":"80","author":"Crew","year":"2020","journal-title":"J Infect"},{"key":"10.1016\/j.nefroe.2026.501554_bib0175","article-title":"Breadth of immune response, immunogenicity, reactogenicity, and safety for a pentavalent meningococcal ABCWY vaccine in healthy adolescents and young adults: results from a phase 3, randomised, controlled observer-blinded trial","author":"Nolan","year":"2024","journal-title":"Lancet Infect Dis"},{"issue":"Pt 1","key":"10.1016\/j.nefroe.2026.501554_bib0180","doi-asserted-by":"crossref","first-page":"126469","DOI":"10.1016\/j.vaccine.2024.126469","article-title":"Randomized trial showing persistence of hSBA titers elicited by a pentavalent meningococcal MenABCWY vaccine for up to 4 years following a primary series and safety and immunogenicity of a booster dose","volume":"43","author":"Peterson","year":"2025","journal-title":"Vaccine"},{"key":"10.1016\/j.nefroe.2026.501554_bib0185","doi-asserted-by":"crossref","DOI":"10.1542\/peds.2014-3503","article-title":"Case report: benefits and challenges of long-term eculizumab in atypical hemolytic uremic syndrome","volume":"135","author":"Cullinan","year":"2015","journal-title":"Pediatrics"},{"key":"10.1016\/j.nefroe.2026.501554_bib0190","doi-asserted-by":"crossref","first-page":"2507","DOI":"10.1016\/j.vaccine.2018.03.087","article-title":"A rare case of septic shock due to Neisseria meningitidis serogroup B infection despite prior vaccination in a young adult with paroxysmal nocturnal haemoglobinuria receiving eculizumab","volume":"36","author":"Reher","year":"2018","journal-title":"Vaccine"},{"key":"10.1016\/j.nefroe.2026.501554_bib0195","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1097\/QCO.0000000000000279","article-title":"Infections associated with the use of eculizumab: recommendations for prevention and prophylaxis","volume":"29","author":"Benamu","year":"2016","journal-title":"Curr Opin Infect Dis"},{"key":"10.1016\/j.nefroe.2026.501554_bib0200","doi-asserted-by":"crossref","first-page":"1396","DOI":"10.1002\/ajh.25642","article-title":"Preventing infectious complications when treating non-malignant immune-mediated hematologic disorders","volume":"94","author":"Malpica","year":"2019","journal-title":"Am J Hematol"}],"container-title":["Nefrolog\u00eda (English Edition)"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S201325142600180X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S201325142600180X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T16:56:27Z","timestamp":1791564987000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S201325142600180X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10]]},"references-count":20,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2026,10]]}},"alternative-id":["S201325142600180X"],"URL":"https:\/\/doi.org\/10.1016\/j.nefroe.2026.501554","relation":{},"ISSN":["2013-2514"],"issn-type":[{"value":"2013-2514","type":"print"}],"subject":[],"published":{"date-parts":[[2026,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Meningococcal meningitis in patients under prolonged eculizumab therapy: Clinical and immunological observations from a case series","name":"articletitle","label":"Article Title"},{"value":"Nefrolog\u00eda (English Edition)","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.nefroe.2026.501554","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Sociedad Espa\u00f1ola de Nefrolog\u00eda. Published by Elsevier Espa\u00f1a, S.L.U.","name":"copyright","label":"Copyright"}],"article-number":"501554"}}